Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

EP Biocomposites Ltd (EPBIO.BO)

Compare
123.00
-2.50
(-1.99%)
At close: 1:15:00 PM GMT+5:30
Loading Chart for EPBIO.BO
  • Previous Close 125.50
  • Open 125.50
  • Bid 123.00 x --
  • Ask 128.00 x --
  • Day's Range 123.00 - 125.50
  • 52 Week Range 105.00 - 230.50
  • Volume 1,500
  • Avg. Volume 2,392
  • Market Cap (intraday) 206.824M
  • Beta (5Y Monthly) -0.93
  • PE Ratio (TTM) 22.65
  • EPS (TTM) 5.43
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

EP Biocomposites Limited manufactures and sells fibre reinforced polymere products in India. The company also offers bio-digestor toilets, sewage and effluent treatment plants, fibre reinforced polymer (FRP) doors, fire doors, and laminated doors; passive fire protection products, including fire rated cable coating system and electrical/plumbing shaft sealing; and FRP allied products, such as FRP garden benches, security cabins, FRP dust bins, FRP tanks, roof tiles, FRP toilets, FRP decorative trims, louvers, FRP frames, FRP hydrant doors, FRP lamp posts, letter boxes, FRP dam doors, hydrant doors, and FRP machine and water meter covers. EP Biocomposites Limited was founded in 1991 and is based in Panaji, India.

epbiocomposites.com

51

Full Time Employees

March 31

Fiscal Year Ends

Recent News: EPBIO.BO

View More

Performance Overview: EPBIO.BO

Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

EPBIO.BO
28.74%
S&P BSE SENSEX (^BSESN)
1.62%

1-Year Return

EPBIO.BO
17.34%
S&P BSE SENSEX (^BSESN)
8.65%

3-Year Return

EPBIO.BO
17.34%
S&P BSE SENSEX (^BSESN)
37.12%

5-Year Return

EPBIO.BO
17.34%
S&P BSE SENSEX (^BSESN)
159.19%

Compare To: EPBIO.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EPBIO.BO

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    211.03M

  • Enterprise Value

    233.55M

  • Trailing P/E

    23.07

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.84

  • Price/Book (mrq)

    2.16

  • Enterprise Value/Revenue

    2.04

  • Enterprise Value/EBITDA

    12.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.91%

  • Return on Assets (ttm)

    7.89%

  • Return on Equity (ttm)

    12.32%

  • Revenue (ttm)

    114.45M

  • Net Income Avi to Common (ttm)

    11.34M

  • Diluted EPS (ttm)

    5.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.22M

  • Total Debt/Equity (mrq)

    36.59%

  • Levered Free Cash Flow (ttm)

    -30.73M

Research Analysis: EPBIO.BO

View More

Company Insights: EPBIO.BO

Research Reports: EPBIO.BO

View More

People Also Watch